Global Amino Acid Metabolism Disorders Treatment Market Insights, Forecast to 2026

  • receipt Report ID : 196553
  • calendar_today Published On: Mar, 2020
  • file_copy Pages: 111
  • list Pharmaceuticals and Healthcare

The key elements of an amino acid are carbon (C), hydrogen (H), oxygen (O), and nitrogen (N), although other elements are found in the side chains of certain amino acids. Some amino acids derivatives are used in pharmaceutical industry. They include 5-HTP (5-hydroxytryptophan) used for experimental treatment of depression, L-DOPA (L-dihydroxyphenylalanine) for Parkinson's treatment, and eflornithine drug that inhibits ornithine decarboxylase and used in the treatment of sleeping sickness. A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive.

In the global market, North America is projected to retain a leading position in the market by the end of 2026 reaching a valuation of over US$359 Mn. It is expected to be closely followed by Europe.

The global Amino Acid Metabolism Disorders Treatment market is valued at 750 million US$ in 2020 and will reach 1160 million US$ by the end of 2026, growing at a CAGR of 5.6% during 2020-2026. The objectives of this study are to define, segment, and project the size of the Amino Acid Metabolism Disorders Treatment market based on company, product type, end user and key regions.

This report studies the global market size of Amino Acid Metabolism Disorders Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Amino Acid Metabolism Disorders Treatment in these regions.

This research report categorizes the global Amino Acid Metabolism Disorders Treatment market by top players/brands, region, type and end user. This report also studies the global Amino Acid Metabolism Disorders Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

GlaxoSmithKline

Pfizer

AMINO

Merck

Recordati

Koninklijke

Sanofi

Shine Star (Hubei) Biological Engineering

Kyowa Hakko Kirin

Market size by Product

Arginine

Folic Acid

Vitamin B6 & B12

Thiamine

Vitamin D

Betaine

Carglumic Acid

Saproterin Dihydrochloride

Others

Market size by End User

Phenylketonuria

Maple Syrup Urine Disease

Argininosuccinic Acidemia

Citrullinemia

Homocystinuria

Market size by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Amino Acid Metabolism Disorders Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2015 to 2019, and forecast to 2026.

To understand the structure of Amino Acid Metabolism Disorders Treatment market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Amino Acid Metabolism Disorders Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Amino Acid Metabolism Disorders Treatment submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Amino Acid Metabolism Disorders Treatment are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Amino Acid Metabolism Disorders Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Study Coverage

1.1 Amino Acid Metabolism Disorders Treatment Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Amino Acid Metabolism Disorders Treatment Market Size Growth Rate by Product

1.4.2 Arginine

1.4.3 Folic Acid

1.4.4 Vitamin B6 & B12

1.4.5 Thiamine

1.4.6 Vitamin D

1.4.7 Betaine

1.4.8 Carglumic Acid

1.4.9 Saproterin Dihydrochloride

1.4.10 Others

1.5 Market by End User

1.5.1 Global Amino Acid Metabolism Disorders Treatment Market Size Growth Rate by End User

1.5.2 Phenylketonuria

1.5.3 Maple Syrup Urine Disease

1.5.4 Argininosuccinic Acidemia

1.5.5 Citrullinemia

1.5.6 Homocystinuria

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Amino Acid Metabolism Disorders Treatment Market Size

2.1.1 Global Amino Acid Metabolism Disorders Treatment Revenue 2015-2026

2.1.2 Global Amino Acid Metabolism Disorders Treatment Sales 2015-2026

2.2 Amino Acid Metabolism Disorders Treatment Growth Rate by Regions

2.2.1 Global Amino Acid Metabolism Disorders Treatment Sales by Regions

2.2.2 Global Amino Acid Metabolism Disorders Treatment Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Amino Acid Metabolism Disorders Treatment Sales by Manufacturers

3.1.1 Amino Acid Metabolism Disorders Treatment Sales by Manufacturers

3.1.2 Amino Acid Metabolism Disorders Treatment Sales Market Share by Manufacturers

3.1.3 Global Amino Acid Metabolism Disorders Treatment Market Concentration Ratio (CR5 and HHI)

3.2 Amino Acid Metabolism Disorders Treatment Revenue by Manufacturers

3.2.1 Amino Acid Metabolism Disorders Treatment Revenue by Manufacturers (2015-2020)

3.2.2 Amino Acid Metabolism Disorders Treatment Revenue Share by Manufacturers (2015-2020)

3.3 Amino Acid Metabolism Disorders Treatment Price by Manufacturers

3.4 Amino Acid Metabolism Disorders Treatment Manufacturing Base Distribution, Product Types

3.4.1 Amino Acid Metabolism Disorders Treatment Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Amino Acid Metabolism Disorders Treatment Product Type

3.4.3 Date of International Manufacturers Enter into Amino Acid Metabolism Disorders Treatment Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Amino Acid Metabolism Disorders Treatment Sales by Product

4.2 Global Amino Acid Metabolism Disorders Treatment Revenue by Product

4.3 Amino Acid Metabolism Disorders Treatment Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Amino Acid Metabolism Disorders Treatment Breakdown Data by End User

6 North America

6.1 North America Amino Acid Metabolism Disorders Treatment by Countries

6.1.1 North America Amino Acid Metabolism Disorders Treatment Sales by Countries

6.1.2 North America Amino Acid Metabolism Disorders Treatment Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Amino Acid Metabolism Disorders Treatment by Product

6.3 North America Amino Acid Metabolism Disorders Treatment by End User

7 Europe

7.1 Europe Amino Acid Metabolism Disorders Treatment by Countries

7.1.1 Europe Amino Acid Metabolism Disorders Treatment Sales by Countries

7.1.2 Europe Amino Acid Metabolism Disorders Treatment Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Amino Acid Metabolism Disorders Treatment by Product

7.3 Europe Amino Acid Metabolism Disorders Treatment by End User

8 Asia Pacific

8.1 Asia Pacific Amino Acid Metabolism Disorders Treatment by Countries

8.1.1 Asia Pacific Amino Acid Metabolism Disorders Treatment Sales by Countries

8.1.2 Asia Pacific Amino Acid Metabolism Disorders Treatment Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Amino Acid Metabolism Disorders Treatment by Product

8.3 Asia Pacific Amino Acid Metabolism Disorders Treatment by End User

9 Central & South America

9.1 Central & South America Amino Acid Metabolism Disorders Treatment by Countries

9.1.1 Central & South America Amino Acid Metabolism Disorders Treatment Sales by Countries

9.1.2 Central & South America Amino Acid Metabolism Disorders Treatment Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Amino Acid Metabolism Disorders Treatment by Product

9.3 Central & South America Amino Acid Metabolism Disorders Treatment by End User

10 Middle East and Africa

10.1 Middle East and Africa Amino Acid Metabolism Disorders Treatment by Countries

10.1.1 Middle East and Africa Amino Acid Metabolism Disorders Treatment Sales by Countries

10.1.2 Middle East and Africa Amino Acid Metabolism Disorders Treatment Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Amino Acid Metabolism Disorders Treatment by Product

10.3 Middle East and Africa Amino Acid Metabolism Disorders Treatment by End User

11 Company Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 Company Business Overview

11.1.3 GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.1.4 GlaxoSmithKline Amino Acid Metabolism Disorders Treatment Products Offered

11.1.5 GlaxoSmithKline Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Company Business Overview

11.2.3 Pfizer Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.2.4 Pfizer Amino Acid Metabolism Disorders Treatment Products Offered

11.2.5 Pfizer Recent Development

11.3 AMINO

11.3.1 AMINO Company Details

11.3.2 Company Business Overview

11.3.3 AMINO Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.3.4 AMINO Amino Acid Metabolism Disorders Treatment Products Offered

11.3.5 AMINO Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Company Business Overview

11.4.3 Merck Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.4.4 Merck Amino Acid Metabolism Disorders Treatment Products Offered

11.4.5 Merck Recent Development

11.5 Recordati

11.5.1 Recordati Company Details

11.5.2 Company Business Overview

11.5.3 Recordati Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.5.4 Recordati Amino Acid Metabolism Disorders Treatment Products Offered

11.5.5 Recordati Recent Development

11.6 Koninklijke

11.6.1 Koninklijke Company Details

11.6.2 Company Business Overview

11.6.3 Koninklijke Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.6.4 Koninklijke Amino Acid Metabolism Disorders Treatment Products Offered

11.6.5 Koninklijke Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Company Business Overview

11.7.3 Sanofi Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.7.4 Sanofi Amino Acid Metabolism Disorders Treatment Products Offered

11.7.5 Sanofi Recent Development

11.8 Shine Star (Hubei) Biological Engineering

11.8.1 Shine Star (Hubei) Biological Engineering Company Details

11.8.2 Company Business Overview

11.8.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.8.4 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorders Treatment Products Offered

11.8.5 Shine Star (Hubei) Biological Engineering Recent Development

11.9 Kyowa Hakko Kirin

11.9.1 Kyowa Hakko Kirin Company Details

11.9.2 Company Business Overview

11.9.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Sales, Revenue and Gross Margin (2015-2020)

11.9.4 Kyowa Hakko Kirin Amino Acid Metabolism Disorders Treatment Products Offered

11.9.5 Kyowa Hakko Kirin Recent Development

12 Future Forecast

12.1 Amino Acid Metabolism Disorders Treatment Market Forecast by Regions

12.1.1 Global Amino Acid Metabolism Disorders Treatment Sales Forecast by Regions 2019-2025

12.1.2 Global Amino Acid Metabolism Disorders Treatment Revenue Forecast by Regions 2019-2025

12.2 Amino Acid Metabolism Disorders Treatment Market Forecast by Product

12.2.1 Global Amino Acid Metabolism Disorders Treatment Sales Forecast by Product 2019-2025

12.2.2 Global Amino Acid Metabolism Disorders Treatment Revenue Forecast by Product 2019-2025

12.3 Amino Acid Metabolism Disorders Treatment Market Forecast by End User

12.4 North America Amino Acid Metabolism Disorders Treatment Forecast

12.5 Europe Amino Acid Metabolism Disorders Treatment Forecast

12.6 Asia Pacific Amino Acid Metabolism Disorders Treatment Forecast

12.7 Central & South America Amino Acid Metabolism Disorders Treatment Forecast

12.8 Middle East and Africa Amino Acid Metabolism Disorders Treatment Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Amino Acid Metabolism Disorders Treatment Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables and Figures

Figure Amino Acid Metabolism Disorders Treatment Product Picture

Table Amino Acid Metabolism Disorders Treatment Market Segments

Table Key Manufacturers Amino A

Please fill the form below, to recieve the report sample


+1